We found CD4 and CD8 T cell response for pre-pandemic sH1N1 was associated with protection against pH1N1 infection, suggesting that subtype- or HA group-specific vaccine with a wider breadth of protection could be a promising first step toward universal influenza vaccine [6, 48]. The gene discussed is CD8A; the disease is influenza.